These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38030253)

  • 1. Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia.
    Mordaunt DA; Stark Z; Santos Gonzalez F; Dalziel K; Goranitis I
    BMJ Open; 2023 Nov; 13(11):e069441. PubMed ID: 38030253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study.
    Mordaunt DA; Gonzalez FS; Lunke S; Eggers S; Sadedin S; Chong B; Dalziel K; Stark Z; Goranitis I
    Genet Med; 2024 Apr; 26(4):101058. PubMed ID: 38164890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol.
    Jayasinghe K; Stark Z; Patel C; Mallawaarachchi A; McCarthy H; Faull R; Chakera A; Sundaram M; Jose M; Kerr P; Wu Y; Wardrop L; Goranitis I; Best S; Martyn M; Quinlan C; Mallett AJ
    BMJ Open; 2019 Aug; 9(8):e029541. PubMed ID: 31383705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcosting diagnostic genomic sequencing: A systematic review.
    Santos Gonzalez F; Mordaunt D; Stark Z; Dalziel K; Christodoulou J; Goranitis I
    Genet Med; 2023 Jun; 25(6):100829. PubMed ID: 36939042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol.
    Bouffler SE; Lee L; Lynch F; Martyn M; Lynch E; Macciocca I; Curnow L; McCorkell G; Lunke S; Chong B; Marum JE; Delatycki M; Downie L; Goranitis I; Vears DF; Best S; Clausen M; Bombard Y; Stark Z; Gaff CL
    BMJ Open; 2023 Jun; 13(6):e072999. PubMed ID: 37270192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safer Baby Bundle: study protocol for the economic evaluation of a quality improvement initiative to reduce stillbirths.
    Callander EJ; Andrews C; Sketcher-Baker K; Nicholl MC; Farrell T; Karger S; Flenady V
    BMJ Open; 2022 Aug; 12(8):e058988. PubMed ID: 36038179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
    Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
    Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation protocol for a multicentre randomised controlled trial to compare Smartphone Cardiac Rehabilitation, Assisted self-Management (SCRAM) versus usual care cardiac rehabilitation among people with coronary heart disease.
    Gao L; Maddison R; Rawstorn J; Ball K; Oldenburg B; Chow C; McNaughton S; Lamb K; Amerena J; Nadurata V; Neil C; Cameron S; Moodie M
    BMJ Open; 2020 Aug; 10(8):e038178. PubMed ID: 32847918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol.
    Prinja S; Singh MP; Guinness L; Rajsekar K; Bhargava B
    BMJ Open; 2020 Jul; 10(7):e035170. PubMed ID: 32690737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing Understanding of Inequities in Rare Disease Genomics.
    Serrano JG; O'Leary M; VanNoy GE; Mangilog BE; Holm IA; Fraiman YS; Rehm HL; O'Donnell-Luria A; Wojcik MH
    Clin Ther; 2023 Aug; 45(8):745-753. PubMed ID: 37517917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining priority indicators of utility for genomic testing in rare disease: A Delphi study.
    Fehlberg Z; Goranitis I; Mallett AJ; Stark Z; Best S
    Genet Med; 2024 Jun; 26(6):101116. PubMed ID: 38459833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia.
    Pan T; Wu Y; Buchanan J; Goranitis I
    Health Qual Life Outcomes; 2023 Dec; 21(1):132. PubMed ID: 38087302
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.